We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
-5.41%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
10 Year Est. Return
AUM
$5.88B
AUM Growth
-$780M
Cap. Flow
-$157M
Cap. Flow %
-2.67%
Top 10 Hldgs %
22.93%
Holding
752
New
180
Increased
134
Reduced
143
Closed
277

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$61.7M
2
BKD icon
Brookdale Senior Living
BKD
+$54.9M
3
LH icon
Labcorp
LH
+$41.3M
4
ZBH icon
Zimmer Biomet
ZBH
+$38.7M
5
PCP
PRECISION CASTPARTS CORP
PCP
+$36.3M

Sector Composition

Rank Sector Weight
1 Healthcare 51.08%
2 Financials 7.25%
3 Energy 5.91%
4 Consumer Discretionary 5.52%
5 Technology 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOLD
26
CALL
DELISTED
Randgold Resources Ltd
GOLD
$45.5M 0.77%
+500,500
New +$40.2M
AIG icon
27
American International
AIG
$41.7B
$40.8M 0.69%
754,040
+46,852
+7% +$2.53M
MED icon
28
Medifast
MED
$109M
$40.8M 0.69%
1,350,000
BKD icon
29
Brookdale Senior Living
BKD
$3.49B
$38.1M 0.65%
2,400,595
-3,596,955
-60% -$54.9M
PRTA icon
30
Prothena Corp
PRTA
$425M
$36.7M 0.62%
891,829
-87,071
-9% -$3.41M
DHR icon
31
Danaher
DHR
$137B
$36.3M 0.62%
569,716
+271,108
+91% +$16.2M
UHS icon
32
Universal Health Services
UHS
$10.2B
$35.5M 0.6%
284,377
+240,139
+543% +$27M
TRP icon
33
TC Energy
TRP
$70.2B
$34.1M 0.58%
867,051
+204,625
+31% +$7.16M
BHI
34
DELISTED
Baker Hughes
BHI
$33.9M 0.58%
773,282
+70,662
+10% +$3.05M
RARE icon
35
Ultragenyx Pharmaceutical
RARE
$2.45B
$33.9M 0.58%
534,791
-95,143
-15% -$6.23M
HD icon
36
Home Depot
HD
$331B
$33.8M 0.57%
252,965
+174,220
+221% +$21.7M
PRGO icon
37
Perrigo
PRGO
$1.4B
$33.7M 0.57%
263,662
-450,907
-63% -$61.7M
SPY icon
38
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$33.6M 0.57%
163,600
+98,600
+152% +$19.2M
DD
39
DELISTED
Du Pont De Nemours E I
DD
$32.5M 0.55%
+513,475
New +$30.7M
HES
40
DELISTED
Hess
HES
$32.4M 0.55%
+615,777
New +$27.2M
MET icon
41
MetLife
MET
$61.9B
$30.8M 0.52%
785,203
+392,503
+100% +$14.7M
AMRI
42
DELISTED
Albany Molecular Research Inc
AMRI
$30.7M 0.52%
2,009,452
-89,348
-4% -$1.4M
V icon
43
Visa
V
$684B
$29.5M 0.5%
385,125
+60,364
+19% +$4.39M
ICLR icon
44
Icon
ICLR
$12.6B
$29M 0.49%
+386,041
New +$27.1M
ZTS icon
45
Zoetis
ZTS
$32.4B
$29M 0.49%
653,125
+239,958
+58% +$10.2M
BAX icon
46
Baxter International
BAX
$13.5B
$28.3M 0.48%
688,320
-345,580
-33% -$13.2M
CRM icon
47
Salesforce
CRM
$151B
$27.4M 0.47%
371,624
+72,445
+24% +$4.99M
CLR
48
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$26.5M 0.45%
871,242
+295,577
+51% +$6.68M
ASND icon
49
Ascendis Pharma A/S
ASND
$16B
$26.1M 0.44%
1,407,350
+37,350
+3% +$663K
CNQ icon
50
Canadian Natural Resources
CNQ
$99.4B
$25.4M 0.43%
+1,945,095
New +$20.7M

Similar funds

Visium Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Visium Asset Management held 752 positions worth $5.88B, down 12% from $6.66B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Visium Asset Management's Q1 2016 filing shows 180 new, 134 increased, 143 reduced and 277 closed positions. Its largest new stake was Biogen: 381,642 shares worth $99.3M. The largest sale was Perrigo, an estimated $61.7M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 51% a quarter earlier, followed by Financials and Energy.

  • Visium Asset Management's largest Q1 2016 buy was Biogen: 381,642 shares worth $99.3M.
  • Visium Asset Management added most to Endo International plc in Q1 2016, an estimated $71.2M increase.
  • Visium Asset Management's biggest Q1 2016 reduction was Perrigo, cutting an estimated $61.7M.
  • Visium Asset Management fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $36.3M.
  • Visium Asset Management's ten largest holdings make up 23% of its $5.88B portfolio in Q1 2016.
  • Visium Asset Management opened 180 new positions and closed 277 in Q1 2016.
  • Visium Asset Management's portfolio value fell 12% quarter-over-quarter to $5.88B.

Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.